342 Participants NeededMy employer runs this trial

Brepocitinib for Hair Loss

(ALPINE Trial)

Recruiting at 4 trial locations
CT
Overseen ByClinical Trial Administrator
Age: 18+
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: Priovant Therapeutics, Inc.
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 18 years old or older.
2. Scalp biopsy consistent with LPP
I currently have active and noticeable symptoms of LPP.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive oral brepocitinib or placebo to evaluate safety and efficacy

12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Brepocitinib

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Brepocitinib Dose Level 1Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Priovant Therapeutics, Inc.

Lead Sponsor

Trials
4
Recruited
570+